APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liranaftate

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liranaftate Market Analysis and Forecast 2026-2032

2 January 2026198 pages

Choose your research edition.

Industry ResearchLiranaftate Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Liranaftate Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Liranaftate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liranaftate Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Liranaftate Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Liranaftate market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Liranaftate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Liranaftate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Liranaftate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liranaftate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Liranaftate include Zenyaku Kogyo Company, Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd, Nanjing Changao Pharmaceutical Co. Ltd, Tianfang Pharmaceutical Co., Ltd, Yangzijiang Pharmaceutical Group Co. Ltd and Zhejiang Wansheng Pharmaceutical Co. Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Liranaftate, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liranaftate, also provides the revenue of main regions and countries. Of the upcoming market potential for Liranaftate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liranaftate revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liranaftate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Liranaftate revenue, projected growth trends, production technology, application and end-user industry.

Liranaftate Segment by Company

Zenyaku Kogyo Company

Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd

Nanjing Changao Pharmaceutical Co. Ltd

Tianfang Pharmaceutical Co., Ltd

Yangzijiang Pharmaceutical Group Co. Ltd

Zhejiang Wansheng Pharmaceutical Co. Ltd

Liranaftate Segment by Type

Cream

Spray

Liranaftate Segment by Application

Tinea Pedis

Jock Itch

Liranaftate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liranaftate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liranaftate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liranaftate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Liranaftate in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Liranaftate company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liranaftate revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liranaftate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cream Major Player Table 3. Spray Major Player Table 4. Global Liranaftate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Tinea Pedis Major Player Table 6. Jock Itch Major Player Table 7. Liranaftate Industry Trends Table 8. Liranaftate Industry Drivers Table 9. Liranaftate Industry Opportunities and Challenges Table 10. Liranaftate Industry Restraints Table 11. Global Liranaftate Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Liranaftate Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Liranaftate Market Share by Region (2021-2026) Table 14. Global Liranaftate Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Liranaftate Market Share by Region (2027-2032) Table 16. Global Liranaftate Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Liranaftate Revenue Market Share by Players (2021-2026) Table 18. Global Liranaftate Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Liranaftate Key Players Headquarters & Area Served Table 20. Global Liranaftate Players, Product Type & Application Table 21. Global Liranaftate Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Liranaftate by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Liranaftate Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Liranaftate Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Liranaftate Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Liranaftate Revenue Market Share by Type (2021-2026) Table 28. Global Liranaftate Revenue Market Share by Type (2027-2032) Table 29. Global Liranaftate Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Liranaftate Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Liranaftate Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Liranaftate Revenue Market Share by Application (2021-2026) Table 33. Global Liranaftate Revenue Market Share by Application (2027-2032) Table 34. Zenyaku Kogyo Company Company Information Table 35. Zenyaku Kogyo Company Business Overview Table 36. Zenyaku Kogyo Company Liranaftate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Zenyaku Kogyo Company Liranaftate Product Portfolio Table 38. Zenyaku Kogyo Company Recent Development Table 39. Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Company Information Table 40. Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Business Overview Table 41. Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Product Portfolio Table 43. Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Recent Development Table 44. Nanjing Changao Pharmaceutical Co. Ltd Company Information Table 45. Nanjing Changao Pharmaceutical Co. Ltd Business Overview Table 46. Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Product Portfolio Table 48. Nanjing Changao Pharmaceutical Co. Ltd Recent Development Table 49. Tianfang Pharmaceutical Co., Ltd Company Information Table 50. Tianfang Pharmaceutical Co., Ltd Business Overview Table 51. Tianfang Pharmaceutical Co., Ltd Liranaftate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Tianfang Pharmaceutical Co., Ltd Liranaftate Product Portfolio Table 53. Tianfang Pharmaceutical Co., Ltd Recent Development Table 54. Yangzijiang Pharmaceutical Group Co. Ltd Company Information Table 55. Yangzijiang Pharmaceutical Group Co. Ltd Business Overview Table 56. Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Product Portfolio Table 58. Yangzijiang Pharmaceutical Group Co. Ltd Recent Development Table 59. Zhejiang Wansheng Pharmaceutical Co. Ltd Company Information Table 60. Zhejiang Wansheng Pharmaceutical Co. Ltd Business Overview Table 61. Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Product Portfolio Table 63. Zhejiang Wansheng Pharmaceutical Co. Ltd Recent Development Table 64. North America Liranaftate Revenue by Type (2021-2026) & (US$ Million) Table 65. North America Liranaftate Revenue by Type (2027-2032) & (US$ Million) Table 66. North America Liranaftate Revenue by Application (2021-2026) & (US$ Million) Table 67. North America Liranaftate Revenue by Application (2027-2032) & (US$ Million) Table 68. North America Liranaftate Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America Liranaftate Revenue by Country (2021-2026) & (US$ Million) Table 70. North America Liranaftate Revenue by Country (US$ Million) & (2027-2032) Table 71. Europe Liranaftate Revenue by Type (2021-2026) & (US$ Million) Table 72. Europe Liranaftate Revenue by Type (2027-2032) & (US$ Million) Table 73. Europe Liranaftate Revenue by Application (2021-2026) & (US$ Million) Table 74. Europe Liranaftate Revenue by Application (2027-2032) & (US$ Million) Table 75. Europe Liranaftate Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe Liranaftate Revenue by Country (2021-2026) & (US$ Million) Table 77. Europe Liranaftate Revenue by Country (US$ Million) & (2027-2032) Table 78. China Liranaftate Revenue by Type (2021-2026) & (US$ Million) Table 79. China Liranaftate Revenue by Type (2027-2032) & (US$ Million) Table 80. China Liranaftate Revenue by Application (2021-2026) & (US$ Million) Table 81. China Liranaftate Revenue by Application (2027-2032) & (US$ Million) Table 82. Asia Liranaftate Revenue by Type (2021-2026) & (US$ Million) Table 83. Asia Liranaftate Revenue by Type (2027-2032) & (US$ Million) Table 84. Asia Liranaftate Revenue by Application (2021-2026) & (US$ Million) Table 85. Asia Liranaftate Revenue by Application (2027-2032) & (US$ Million) Table 86. Asia Liranaftate Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia Liranaftate Revenue by Region (US$ Million) & (2021-2026) Table 88. Asia Liranaftate Revenue by Region (US$ Million) & (2027-2032) Table 89. SAMEA Liranaftate Revenue by Type (2021-2026) & (US$ Million) Table 90. SAMEA Liranaftate Revenue by Type (2027-2032) & (US$ Million) Table 91. SAMEA Liranaftate Revenue by Application (2021-2026) & (US$ Million) Table 92. SAMEA Liranaftate Revenue by Application (2027-2032) & (US$ Million) Table 93. SAMEA Liranaftate Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. SAMEA Liranaftate Revenue by Country (2021-2026) & (US$ Million) Table 95. SAMEA Liranaftate Revenue by Country (US$ Million) & (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Liranaftate Image Figure 2. Global Liranaftate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liranaftate Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cream Image Figure 5. Spray Image Figure 6. Global Liranaftate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Liranaftate Market Size Share 2021 VS 2025 VS 2032 Figure 8. Tinea Pedis Image Figure 9. Jock Itch Image Figure 10. Global Liranaftate Market Size (US$ Million) & (2021-2032) Figure 11. Global Liranaftate Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Liranaftate Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Liranaftate Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Liranaftate Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Liranaftate Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Liranaftate Revenue Market Share by Type (2021-2032) Figure 18. Global Liranaftate Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Liranaftate Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Liranaftate Revenue Market Share by Application (2021-2032) Figure 21. North America Liranaftate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Liranaftate Revenue Share by Type (2021-2032) Figure 23. North America Liranaftate Revenue Share by Application (2021-2032) Figure 24. North America Liranaftate Revenue Share by Country (2021-2032) Figure 25. United States Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Liranaftate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Liranaftate Revenue Share by Type (2021-2032) Figure 30. Europe Liranaftate Revenue Share by Application (2021-2032) Figure 31. Europe Liranaftate Revenue Share by Country (2021-2032) Figure 32. Germany Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Liranaftate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Liranaftate Revenue Share by Type (2021-2032) Figure 42. China Liranaftate Revenue Share by Application (2021-2032) Figure 43. Asia Liranaftate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Liranaftate Revenue Share by Type (2021-2032) Figure 45. Asia Liranaftate Revenue Share by Application (2021-2032) Figure 46. Asia Liranaftate Revenue Share by Region (2021-2032) Figure 47. Japan Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Liranaftate Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Liranaftate Revenue Share by Type (2021-2032) Figure 55. SAMEA Liranaftate Revenue Share by Application (2021-2032) Figure 56. SAMEA Liranaftate Revenue Share by Country (2021-2032) Figure 57. Brazil Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Liranaftate Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Cream
  • Spray
Applications
  • Tinea Pedis
  • Jock Itch
Companies covered
  • Zenyaku Kogyo Company
  • Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
  • Nanjing Changao Pharmaceutical Co. Ltd
  • Tianfang Pharmaceutical Co., Ltd
  • Yangzijiang Pharmaceutical Group Co. Ltd
  • Zhejiang Wansheng Pharmaceutical Co. Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liranaftate Market by Type
  3. 1.2.1 Global Liranaftate Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cream
  5. 1.2.3 Spray
  6. 1.3 Liranaftate Market by Application
  7. 1.3.1 Global Liranaftate Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Tinea Pedis
  9. 1.3.3 Jock Itch
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Liranaftate Market Dynamics
  1. 2.1 Liranaftate Industry Trends
  2. 2.2 Liranaftate Industry Drivers
  3. 2.3 Liranaftate Industry Opportunities and Challenges
  4. 2.4 Liranaftate Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Liranaftate Market Perspective (2021-2032)
  2. 3.2 Global Liranaftate Growth Trends by Region
  3. 3.2.1 Global Liranaftate Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liranaftate Market Size by Region (2021-2026)
  5. 3.2.3 Global Liranaftate Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Liranaftate Revenue by Players
  2. 4.1.1 Global Liranaftate Revenue by Players (2021-2026)
  3. 4.1.2 Global Liranaftate Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Liranaftate Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liranaftate Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Liranaftate Key Players Headquarters & Area Served
  7. 4.4 Global Liranaftate Players, Product Type & Application
  8. 4.5 Global Liranaftate Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Liranaftate Market CR5 and HHI
  11. 4.6.3 2025 Liranaftate Tier 1, Tier 2, and Tier 3
5 Liranaftate Market Size by Type
  1. 5.1 Global Liranaftate Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Liranaftate Revenue by Type (2021-2032)
  3. 5.3 Global Liranaftate Revenue Market Share by Type (2021-2032)
6 Liranaftate Market Size by Application
  1. 6.1 Global Liranaftate Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Liranaftate Revenue by Application (2021-2032)
  3. 6.3 Global Liranaftate Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Zenyaku Kogyo Company
  2. 7.1.1 Zenyaku Kogyo Company Company Information
  3. 7.1.2 Zenyaku Kogyo Company Business Overview
  4. 7.1.3 Zenyaku Kogyo Company Liranaftate Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Zenyaku Kogyo Company Liranaftate Product Portfolio
  6. 7.1.5 Zenyaku Kogyo Company Recent Developments
  7. 7.2 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
  8. 7.2.1 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Company Information
  9. 7.2.2 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Business Overview
  10. 7.2.3 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Product Portfolio
  12. 7.2.5 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Recent Developments
  13. 7.3 Nanjing Changao Pharmaceutical Co. Ltd
  14. 7.3.1 Nanjing Changao Pharmaceutical Co. Ltd Company Information
  15. 7.3.2 Nanjing Changao Pharmaceutical Co. Ltd Business Overview
  16. 7.3.3 Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Product Portfolio
  18. 7.3.5 Nanjing Changao Pharmaceutical Co. Ltd Recent Developments
  19. 7.4 Tianfang Pharmaceutical Co., Ltd
  20. 7.4.1 Tianfang Pharmaceutical Co., Ltd Company Information
  21. 7.4.2 Tianfang Pharmaceutical Co., Ltd Business Overview
  22. 7.4.3 Tianfang Pharmaceutical Co., Ltd Liranaftate Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Tianfang Pharmaceutical Co., Ltd Liranaftate Product Portfolio
  24. 7.4.5 Tianfang Pharmaceutical Co., Ltd Recent Developments
  25. 7.5 Yangzijiang Pharmaceutical Group Co. Ltd
  26. 7.5.1 Yangzijiang Pharmaceutical Group Co. Ltd Company Information
  27. 7.5.2 Yangzijiang Pharmaceutical Group Co. Ltd Business Overview
  28. 7.5.3 Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Product Portfolio
  30. 7.5.5 Yangzijiang Pharmaceutical Group Co. Ltd Recent Developments
  31. 7.6 Zhejiang Wansheng Pharmaceutical Co. Ltd
  32. 7.6.1 Zhejiang Wansheng Pharmaceutical Co. Ltd Company Information
  33. 7.6.2 Zhejiang Wansheng Pharmaceutical Co. Ltd Business Overview
  34. 7.6.3 Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Product Portfolio
  36. 7.6.5 Zhejiang Wansheng Pharmaceutical Co. Ltd Recent Developments
8 North America
  1. 8.1 North America Liranaftate Revenue (2021-2032)
  2. 8.2 North America Liranaftate Revenue by Type (2021-2032)
  3. 8.2.1 North America Liranaftate Revenue by Type (2021-2026)
  4. 8.2.2 North America Liranaftate Revenue by Type (2027-2032)
  5. 8.3 North America Liranaftate Revenue Share by Type (2021-2032)
  6. 8.4 North America Liranaftate Revenue by Application (2021-2032)
  7. 8.4.1 North America Liranaftate Revenue by Application (2021-2026)
  8. 8.4.2 North America Liranaftate Revenue by Application (2027-2032)
  9. 8.5 North America Liranaftate Revenue Share by Application (2021-2032)
  10. 8.6 North America Liranaftate Revenue by Country
  11. 8.6.1 North America Liranaftate Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Liranaftate Revenue by Country (2021-2026)
  13. 8.6.3 North America Liranaftate Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Liranaftate Revenue (2021-2032)
  2. 9.2 Europe Liranaftate Revenue by Type (2021-2032)
  3. 9.2.1 Europe Liranaftate Revenue by Type (2021-2026)
  4. 9.2.2 Europe Liranaftate Revenue by Type (2027-2032)
  5. 9.3 Europe Liranaftate Revenue Share by Type (2021-2032)
  6. 9.4 Europe Liranaftate Revenue by Application (2021-2032)
  7. 9.4.1 Europe Liranaftate Revenue by Application (2021-2026)
  8. 9.4.2 Europe Liranaftate Revenue by Application (2027-2032)
  9. 9.5 Europe Liranaftate Revenue Share by Application (2021-2032)
  10. 9.6 Europe Liranaftate Revenue by Country
  11. 9.6.1 Europe Liranaftate Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Liranaftate Revenue by Country (2021-2026)
  13. 9.6.3 Europe Liranaftate Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Liranaftate Revenue (2021-2032)
  2. 10.2 China Liranaftate Revenue by Type (2021-2032)
  3. 10.2.1 China Liranaftate Revenue by Type (2021-2026)
  4. 10.2.2 China Liranaftate Revenue by Type (2027-2032)
  5. 10.3 China Liranaftate Revenue Share by Type (2021-2032)
  6. 10.4 China Liranaftate Revenue by Application (2021-2032)
  7. 10.4.1 China Liranaftate Revenue by Application (2021-2026)
  8. 10.4.2 China Liranaftate Revenue by Application (2027-2032)
  9. 10.5 China Liranaftate Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liranaftate Revenue (2021-2032)
  2. 11.2 Asia Liranaftate Revenue by Type (2021-2032)
  3. 11.2.1 Asia Liranaftate Revenue by Type (2021-2026)
  4. 11.2.2 Asia Liranaftate Revenue by Type (2027-2032)
  5. 11.3 Asia Liranaftate Revenue Share by Type (2021-2032)
  6. 11.4 Asia Liranaftate Revenue by Application (2021-2032)
  7. 11.4.1 Asia Liranaftate Revenue by Application (2021-2026)
  8. 11.4.2 Asia Liranaftate Revenue by Application (2027-2032)
  9. 11.5 Asia Liranaftate Revenue Share by Application (2021-2032)
  10. 11.6 Asia Liranaftate Revenue by Country
  11. 11.6.1 Asia Liranaftate Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Liranaftate Revenue by Country (2021-2026)
  13. 11.6.3 Asia Liranaftate Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liranaftate Revenue (2021-2032)
  2. 12.2 SAMEA Liranaftate Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Liranaftate Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Liranaftate Revenue by Type (2027-2032)
  5. 12.3 SAMEA Liranaftate Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Liranaftate Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Liranaftate Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Liranaftate Revenue by Application (2027-2032)
  9. 12.5 SAMEA Liranaftate Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Liranaftate Revenue by Country
  11. 12.6.1 SAMEA Liranaftate Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Liranaftate Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Liranaftate Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst